Stock 4005 NATIONAL MEDICAL CARE COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Ratings National Medical Care Company

Equities

4005

SA139051UIH0

Market Closed - Saudi Arabian S.E.
Other stock markets
 08:20:04 2024-06-04 am EDT 		5-day change 1st Jan Change
193.8 SAR -1.82% Intraday chart for National Medical Care Company +10.74% +11.12%
May. 23 National Medical Care Company Approves Cash Dividend for the Financial Period December 31, 2023, Payable on 12 June 2024 CI
May. 15 National Medical Care Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 49% by 2026.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 30.16 times its estimated earnings per share for the ongoing year.
  • Based on current prices, the company has particularly high valuation levels.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The company is highly valued given the cash flows generated by its activity.
  • The company is not the most generous with respect to shareholders' compensation.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
NATIONAL MEDICAL CARE COMPANY Stock National Medical Care Company
+11.12% 2.36B -
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-23.70% 15.44B
B+
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
-1.80% 11.7B
B
IHH HEALTHCARE Stock IHH Healthcare
+2.65% 11.58B
B+
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+2.48% 10.12B
B+
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+26.77% 8.42B
B
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+7.94% 6.76B
B-
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+0.18% 6.08B
D
DALLAH HEALTHCARE COMPANY Stock Dallah Healthcare Company
-3.49% 4.33B -
FORTIS HEALTHCARE LIMITED Stock Fortis Healthcare Limited
+4.81% 4.17B
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 4005 Stock
  4. Ratings National Medical Care Company